Fragile X Research Q&A: Dr. Berry-Kravis on the RECONNECT Trial

Join Elizabeth M. Berry-Kravis, MD, PhD for a live Q&A session on the recently announced results of Harmony Biosciences’ Phase 3 RECONNECT trial of ZYN002 in Fragile X syndrome.

This session will provide an opportunity for families and community members to ask questions and hear Dr. Berry-Kravis share her perspective on why the trial may not have met its primary goal, including challenges of outcome measures and the impact of placebo effects.

The webinar will be recorded and published on FRAXA’s YouTube channel. You may also register in advance to submit a question, even if you cannot attend live.

By registering, you can also sign up for our newsletter to be notified when the recording is available and to stay updated on Fragile X research news.